NFT đang trải qua thời kỳ phục hưng, nhưng liệu người đồng sáng lập Solana có đang dội nước lạnh vào nó không?

Keiretsu Forum Mid Atlantic

investment firm

About

Keiretsu Forum Mid-Atlantic offers you access to a wealth of international angel funding opportunities, vetted by business experts with

Details

Founded date
Jan 1, 2010
Operating Status
Active
Investor Type
Venture Capital

Keiretsu Forum Mid-Atlantic offers you access to a wealth of international angel funding opportunities, vetted by business experts with local first hand knowledge of every investment.

Investments

Number of Investments
Number of Lead Investments
10
5
Keiretsu Forum Mid Atlantic has made 10 investments. Their most recent investment was on Oct 19, 2022, when FEMSelect raised $9M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 19, 2022 FEMSelect
Series B $9M Health Care
Aug 31, 2022 iQure Pharma
Series A $600K Biotechnology Yes
Series A $3M Battery Yes
Jul 1, 2019 ExpressCells
Series A $1.20M Biotechnology Yes
Mar 7, 2019 Astarte Medical
Series A $5M Analytics

Employee Profiles

Number of Employee Profiles
3
Keiretsu Forum Mid Atlantic has 3 current employee profiles, including Executive Vincent Leusner
Executive
Executive
Executive

Exits

Keiretsu Forum Mid Atlantic has had 1 exits. Keiretsu Forum Mid Atlantic most notable exits include Savara Pharmaceuticals

Date Company Name Exit Type Industry
Jun 1, 2017 Savara Pharmaceuticals M&A Biopharma Detail